WALD WALDENCAST ACQUISITION CORP

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection

New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion



NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation and the originator of medical-grade skincare, proudly unveils the latest groundbreaking additions to its highly regarded SUZANOBAGIMD® collection. The new products - Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream - offer cutting-edge solutions to address common skincare concerns such as skin discoloration and brightening, oxidative stress, and skin hydration to maintain a healthy skin barrier function. Formulated to be safe and effective for all skin types—whether sensitive, oily, dry, or somewhere in between—Obagi’s inclusive approach ensures that everyone can experience the benefits of advanced skincare, no matter their unique needs or concerns.

Developed by Dr. Suzan Obagi, a distinguished dermatologist and the Chief Medical Director at Obagi, the powerhouse duo of skincare solutions reflects her extensive research and expertise in dermatologic surgery and skin health. Her expertise in formulation is drawn from her extensive experience treating thousands of patients each year, addressing a wide range of concerns. The most common issues she observes are hyperpigmentation and challenges with sensitive skin. Dr. Obagi’s groundbreaking work, especially in understanding the unique needs of skin of color and the needs of sensitive skin types, led her to identify the five key pathways essential for optimal skin health. These pathways include reducing pigment formation and visibly improving hyperpigmentation, calming redness and reducing skin irritation, combating oxidative stress, supporting cell turnover, and restoring the skin barrier. Dr. Obagi has created effective products that do not irritate the skin while delivering results you can see in as little as a few weeks in some cases.

Dr. Suzan Obagi, Chief Medical Director at Obagi, commented, “I am so excited to finally share these groundbreaking innovations with the world. These products are the culmination of years of research and patient testing, driven by my passion for helping patients unveil their naturally radiant skin without irritation. By incorporating cutting-edge ingredients like encapsulated silymarin to protect against oxidative stress and multi-weight hyaluronic acids for multi-layered hydration, we’ve developed solutions that truly push the envelope in skincare. I genuinely believe these novel formulations not only set a new standard but also reflect my unwavering commitment to treating skin holistically, ensuring health, resilience, and a luminous glow for every skin type.”

Drawing on this wealth of expertise in treating skin discoloration, Dr. Obagi formulated these latest additions to her namesake collection to transform skin health and deliver a radiant, brighter complexion. The collection includes the new Super Antioxidant Serum, providing medical-grade defense against oxidative stress for more resilient, radiant and youthful-looking skin. Super Antioxidant Serum is formulated with a potent blend of antioxidants, including encapsulated Silymarin and stabilized Vitamin C, to neutralize free radicals, combat oxidative stress, and brighten skin.

Moisture Restore Hydration Replenishing Cream is a medical-grade, multi-layered moisturizer which delivers intense, multi-layered hydration. With a blend of both low and high-molecular-weight Hyaluronic Acids this cream delivers moisture to different layers of the skin.

Delivering both immediate and long-lasting results, these products were clinically tested by Dr. Obagi and third party clinical graders. During testing of Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream, 94% of subjects felt their skin was refreshed and smoother immediately after a single application* and 97% of subjects observed an improvement in overall skin appearance after 2 weeks* including:

  • Visible improvement in the appearance of fine lines
  • Visible improvement in the appearance of hyperpigmentation
  • Visibly calms irritation and boosts hydration

Justin Giouzepis, Chief Marketing Officer of Obagi, added, “We’re thrilled to partner with Dr. Suzan Obagi on bringing to market Super Antioxidant Serum and Moisture Restore, products designed to address the critical needs of both skin brightening and hydration. Obagi is the leader in innovating products that defend against environmental aggressors with our vitamin C collection and products that treat hyperpigmentation with the Obagi Nu-Derm® collection. Having Super Antioxidant Serum in the Obagi portfolio provides professionals with an additional oxidative stress fighting product to recommend to their patients who may have sensitive skin but don’t want to compromise on results. We know achieving radiant, healthy skin shouldn't come at the cost of irritation, which is why we've prioritized gentle yet effective formulations suitable for even the most sensitive skin types. These launches represent our commitment to providing inclusive skincare solutions for everyone."

The SUZANOBAGIMD® Super Antioxidant Serum, priced at $158, and the SUZANOBAGIMD® Moisture Restore Hydration Replenishing Cream, priced at $78, are now available through partnering professional channels. They will be available for customers to purchase on on 2.24.2025.

*Results are based on a 2024 2-week clinical test, with subjects using SOMD Super Antioxidant Serum & Moisture Restore Replenishing Cream (if needed) daily within protocol.

About Obagi Medical

Obagi Medical is an industry-leading, advanced skincare line rooted in research and skin biology, refined with a legacy of 35 years’ experience. First known as leaders in the treatment of hyperpigmentation with the Obagi Nu-Derm® System, Obagi products are designed to diminish the appearance of premature aging, photodamage, skin discoloration, acne, and sun damage. Backed by science and trusted by professionals, Obagi empowers individuals to achieve healthy, beautiful skin.

More information about Obagi is available on the brand’s website, .

About Waldencast

Founded by Michel Brousset and Hind Sebti, Waldencast’s ambition is to build a global best-in-class beauty and wellness operating platform by developing, acquiring, accelerating, and scaling conscious, high-growth purpose-driven brands. Waldencast’s vision is fundamentally underpinned by its brand-led business model that ensures proximity to its customers, business agility, and market responsiveness, while maintaining each brand’s distinct DNA. The first step in realizing its vision was the business combination with Obagi Cosmeceuticals and Milk Makeup. As part of the Waldencast platform, its brands will benefit from the operational scale of a multi-brand platform; the expertise in managing global beauty brands at scale; a balanced portfolio to mitigate category fluctuations; asset-light efficiency; and the market responsiveness and speed of entrepreneurial indie brands. For more information please visit: .

Media Contact:

A photo accompanying this announcement is available at



EN
10/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on WALDENCAST ACQUISITION CORP

 PRESS RELEASE

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results

Waldencast Reports Q4 2024 and Fiscal Year 2024 Financial Results Q4 Net Revenue of $72.1 million, 29.4% Comparable Net Revenue Growth and $11.2 million of Adjusted EBITDA, doubling from Q4 2023 FY 2024 Net Revenue of $273.9 million, 27.5% Comparable Net Revenue Growth and $40.3 million of Adjusted EBITDA Obagi Medical is the fastest growing professional skincare brand1 in the US in 2024 Milk Makeup expands its distribution to Ulta Beauty Waldencast secures a new $205 million credit facility, replacing the current one, enhancing flexibility and extending debt maturity LONDON, March 18...

 PRESS RELEASE

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results C...

Waldencast plc Announces Fourth Quarter and Fiscal Year 2024 Results Conference Call and Webcast LONDON, March 11, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform provided the details for its Fourth Quarter and Fiscal Year 2024 conference call and webcast. As previously announced, the Company will issue its Fourth Quarter and Fiscal Year 2024 results on March 18, 2025 after the close of the U.S. market. Management will host a conference call to discuss its Fourth Quarter and Fiscal Year 2024 results on March 19, 20...

 PRESS RELEASE

Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing ...

Waldencast Announces Participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit LONDON, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), a global multi-brand beauty and wellness platform, today announced its participation in the TD Cowen 2nd Annual Glowing Ahead: Beauty & Wellness Summit being held on February 26, 2025 in New York, New York. Michel Brousset, Founder and Chief Executive Officer will participate in a fireside chat presentation on Wednesday, February 26, 2025 at 2:45 p.m. Eastern Standard Time and host me...

 PRESS RELEASE

Obagi Medical Announces the Launch of Latest Innovations in The SUZANO...

Obagi Medical Announces the Launch of Latest Innovations in The SUZANOBAGIMD® Collection New Skincare Solutions to Target Skin Brightening, Oxidative Stress, and Hydration for a Healthier, More Radiant Complexion NEW YORK, Feb. 10, 2025 (GLOBE NEWSWIRE) -- Obagi Medical (“Obagi”), a leader in advanced skincare innovation and the originator of medical-grade skincare, proudly unveils the latest groundbreaking additions to its highly regarded SUZANOBAGIMD® collection. The new products - Super Antioxidant Serum and Moisture Restore Hydration Replenishing Cream - offer cutting-edge solutio...

 PRESS RELEASE

Waldencast plc Announces Upcoming Earnings Release and Conference Call...

Waldencast plc Announces Upcoming Earnings Release and Conference Call Dates LONDON, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Waldencast plc, (NASDAQ: WALD) (“Waldencast”), a global multi-brand beauty and wellness platform, announced upcoming earnings release, conference call and webcast information for the fourth quarter and full fiscal year 2024 and first, second, and third quarters of fiscal year 2025. The webcasts will be available on the Investor Relations page on the company's website at  approximately 2 weeks prior to the events. For the fourth quarter and full fiscal year 2024, the Comp...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch